{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T22:36:24Z","timestamp":1720391784021},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Confidence in Concept"},{"name":"Oxford Glycobiology Endowment, the Department of Biochemistry"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.molimm.2015.08.014","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T14:29:13Z","timestamp":1443882553000},"page":"234-243","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor"],"prefix":"10.1016","volume":"68","author":[{"given":"Snezana","family":"Vasiljevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma V.","family":"Beale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Bonomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iona S.","family":"Easthope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma E.","family":"Seabright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro T.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher N.","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Dalziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. (1) October","key":"10.1016\/j.molimm.2015.08.014_bib0005","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.gt.3302612","article-title":"Gutless adenovirus: last-generation adenovirus for gene therapy","volume":"12","author":"Alba","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.molimm.2015.08.014_bib0010","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1371\/journal.pone.0001413","article-title":"Human IgG\/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis","volume":"3","author":"Allhorn","year":"2008","journal-title":"PLoS One"},{"issue":"August","key":"10.1016\/j.molimm.2015.08.014_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"June","key":"10.1016\/j.molimm.2015.08.014_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2012.04.002","article-title":"Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions","volume":"420","author":"Baruah","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2015.08.014_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-398342-8.00002-1","article-title":"Chapter two\u2014adenovirus strategies for tissue-specific targeting","volume":"115","author":"Beatty","year":"2012","journal-title":"Adv. Cancer Res."},{"issue":"February","key":"10.1016\/j.molimm.2015.08.014_bib0030","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"issue":"October","key":"10.1016\/j.molimm.2015.08.014_bib0035","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1021\/ja306068g","article-title":"Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis","volume":"134","author":"Bowden","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"September","key":"10.1016\/j.molimm.2015.08.014_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chroma.2013.07.104","article-title":"A cost-effective plate-based sample preparation for antibody N-glycan analysis","volume":"1307","author":"Burnina","year":"2013","journal-title":"J. Chromatogr. A"},{"issue":"May","key":"10.1016\/j.molimm.2015.08.014_bib0045","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","article-title":"Humanization of an anti-p185HER2 antibody for human cancer therapy","volume":"89","author":"Carter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"December","key":"10.1016\/j.molimm.2015.08.014_bib0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1023\/A:1007183915921","article-title":"Lectin analysis of human immunoglobulin G N-glycan sialylation","volume":"16","author":"Dalziel","year":"1999","journal-title":"Glycoconj. J."},{"issue":"October","key":"10.1016\/j.molimm.2015.08.014_bib0055","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.gt.3301301","article-title":"Production of first generation adenovirus vectors: a review","volume":"7","author":"Danthinne","year":"2000","journal-title":"Gene Ther."},{"issue":"August","key":"10.1016\/j.molimm.2015.08.014_bib0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/imt.11.87","article-title":"Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment","volume":"3","author":"DeRose","year":"2011","journal-title":"Immunotherapy"},{"issue":"May 16 (20)","key":"10.1016\/j.molimm.2015.08.014_bib0065","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.1074\/jbc.M113.532812","article-title":"Fragments of bacterial endoglycosidase S and immunoglobulin G reveal subdomains of each that contribute to deglycosylation","volume":"289","author":"Dixon","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"August","key":"10.1016\/j.molimm.2015.08.014_bib0070","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","article-title":"Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells","volume":"74","author":"Dmitriev","year":"2000","journal-title":"J. Virol."},{"issue":"January","key":"10.1016\/j.molimm.2015.08.014_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jmb.2010.10.040","article-title":"Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting","volume":"405","author":"Dreier","year":"2011","journal-title":"J. Mol. Biol."},{"issue":"March","key":"10.1016\/j.molimm.2015.08.014_bib0080","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.1073\/pnas.1213653110","article-title":"Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters","volume":"110","author":"Dreier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"January","key":"10.1016\/j.molimm.2015.08.014_bib0085","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"April","key":"10.1016\/j.molimm.2015.08.014_bib0090","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1158\/1078-0432.CCR-03-0448","article-title":"HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice","volume":"10","author":"Finkle","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"March","key":"10.1016\/j.molimm.2015.08.014_bib0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world\u2019s first oncolytic virus therapy for cancer treatment","volume":"98","author":"Garber","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"November","key":"10.1016\/j.molimm.2015.08.014_bib0100","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1158\/1078-0432.CCR-11-1074","article-title":"Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors","volume":"17","author":"Gerber","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"May","key":"10.1016\/j.molimm.2015.08.014_bib0105","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1021\/ja301334b","article-title":"An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling","volume":"134","author":"Goodfellow","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"June","key":"10.1016\/j.molimm.2015.08.014_bib0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.cgt.7700198","article-title":"Targeting of adenoviral vectors through a bispecific single-chain antibody","volume":"7","author":"Haisma","year":"2000","journal-title":"Cancer Gene Ther."},{"issue":"November","key":"10.1016\/j.molimm.2015.08.014_bib0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10719-008-9226-5","article-title":"Identification of high-mannose and multiantennary complex-type N-linked glycans containing alpha-galactose epitopes from Nurse shark IgM heavy chain","volume":"26","author":"Harvey","year":"2009","journal-title":"Glycoconj. J."},{"issue":"August","key":"10.1016\/j.molimm.2015.08.014_bib0120","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1128\/JVI.68.8.5239-5246.1994","article-title":"Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli","volume":"68","author":"Henry","year":"1994","journal-title":"J. Virol."},{"issue":"May","key":"10.1016\/j.molimm.2015.08.014_bib0125","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/emboj\/16.9.2294","article-title":"Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells","volume":"16","author":"Hong","year":"1997","journal-title":"EMBO J."},{"issue":"November (6)","key":"10.1016\/j.molimm.2015.08.014_bib0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2007.08.002","article-title":"Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells","volume":"123","author":"Jung","year":"2007","journal-title":"J. Control Release"},{"issue":"January","key":"10.1016\/j.molimm.2015.08.014_bib0135","first-page":"609","article-title":"Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain","volume":"62","author":"Kashentseva","year":"2002","journal-title":"Cancer Res."},{"issue":"September","key":"10.1016\/j.molimm.2015.08.014_bib0140","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ijc.25758","article-title":"EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus","volume":"129","author":"Kawashima","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"February","key":"10.1016\/j.molimm.2015.08.014_bib0145","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1128\/JVI.76.4.1892-1903.2002","article-title":"Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization","volume":"76","author":"Kim","year":"2002","journal-title":"J. Virol."},{"issue":"December","key":"10.1016\/j.molimm.2015.08.014_bib0150","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1128\/JVI.77.24.12931-12940.2003","article-title":"Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge","volume":"77","author":"Korokhov","year":"2003","journal-title":"J. Virol."},{"issue":"February","key":"10.1016\/j.molimm.2015.08.014_bib0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-1702(02)00274-5","article-title":"Adaptable modification of adenoviral tropism using a bifunctional ligand protein","volume":"91","author":"Li","year":"2003","journal-title":"Virus Res."},{"issue":"October","key":"10.1016\/j.molimm.2015.08.014_bib0160","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbrc.2003.08.101","article-title":"Comparative transductions of breast cancer cells by three DNA viruses","volume":"309","author":"Lucas","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"April","key":"10.1016\/j.molimm.2015.08.014_bib0165","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J. Immunol."},{"issue":"July\u2013August","key":"10.1016\/j.molimm.2015.08.014_bib0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jgm.285","article-title":"Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability","volume":"4","author":"Magnusson","year":"2002","journal-title":"J. Gene Med."},{"issue":"January","key":"10.1016\/j.molimm.2015.08.014_bib0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/hum.2011.016","article-title":"A transductionally retargeted adenoviral vector for virotherapy of Her2\/neu-expressing prostate cancer","volume":"23","author":"Magnusson","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"February","key":"10.1016\/j.molimm.2015.08.014_bib0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/pr800704t","article-title":"Development of a single column method for the separation of lipid- and protein-derived oligosaccharides","volume":"8","author":"Neville","year":"2009","journal-title":"J. Proteome Res."},{"issue":"May","key":"10.1016\/j.molimm.2015.08.014_bib0185","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O\u2019Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.molimm.2015.08.014_bib0190","doi-asserted-by":"crossref","first-page":"e67091","DOI":"10.1371\/journal.pone.0067091","article-title":"Development of adenoviral delivery systems to target hepatic stellate cells in vivo","volume":"8","author":"Reetz","year":"2013","journal-title":"PLoS One"},{"issue":"January","key":"10.1016\/j.molimm.2015.08.014_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/mabs.27333","article-title":"Antibodies to watch in 2014","volume":"6","author":"Reichert","year":"2014","journal-title":"mAbs"},{"issue":"May","key":"10.1016\/j.molimm.2015.08.014_bib0200","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1046\/j.1432-1033.2003.03596.x","article-title":"A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells","volume":"270","author":"Richards","year":"2003","journal-title":"Eur. J. Biochem.\/FEBS"},{"issue":"August","key":"10.1016\/j.molimm.2015.08.014_bib0205","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1061692","article-title":"Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design","volume":"293","author":"Saphire","year":"2001","journal-title":"Science"},{"issue":"December","key":"10.1016\/j.molimm.2015.08.014_bib0210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jgm.1112","article-title":"Enhanced transduction of dendritic cells by Fc\u03b3RI-targeted adenovirus vectors","volume":"9","author":"Sapinoro","year":"2007","journal-title":"J. Gene Med."},{"issue":"April","key":"10.1016\/j.molimm.2015.08.014_bib0215","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnci\/djk134","article-title":"Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer","volume":"99","author":"Scaltriti","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"June","key":"10.1016\/j.molimm.2015.08.014_bib0220","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-06-0024","article-title":"Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors","volume":"12","author":"Tanaka","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"February","key":"10.1016\/j.molimm.2015.08.014_bib0225","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/JVI.77.3.2093-2104.2003","article-title":"Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin G-binding domain in the capsid","volume":"77","author":"Volpers","year":"2003","journal-title":"J. Virol."},{"issue":"October","key":"10.1016\/j.molimm.2015.08.014_bib0230","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.gt.3300511","article-title":"The \u2018adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery","volume":"4","author":"Watkins","year":"1997","journal-title":"Gene Therapy"},{"issue":"April","key":"10.1016\/j.molimm.2015.08.014_bib0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2015.08.014_bib0240","doi-asserted-by":"crossref","first-page":"e0132011","DOI":"10.1371\/journal.pone.0132011","article-title":"Complete removal of extracellular IgG antibodies in a randomized dose-escalation Phase I Study with the bacterial enzyme ides - a novel therapeutic opportunity","volume":"10","author":"Winstedt","year":"2015","journal-title":"PLoS One"},{"issue":"July","key":"10.1016\/j.molimm.2015.08.014_bib0245","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1021\/ja4014375","article-title":"Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies","volume":"135","author":"Yu","year":"2013","journal-title":"J. Am. Chem. Soc."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015300626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015300626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T05:13:26Z","timestamp":1599628406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589015300626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0161589015300626"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2015.08.014","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2015.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}